Liposomal composition and methods for the production and use thereof

A liposome composition with a specific phospholipid coating and low humidity formulation addresses the complexity and toxicity issues of existing methods, achieving stable and bioavailable bioactive substances that form liposomes upon hydration.

HK40135203APending Publication Date: 2026-07-17NL CONDINANT LTD

Patent Information

Authority / Receiving Office
HK · HK
Patent Type
Applications
Current Assignee / Owner
NL CONDINANT LTD
Filing Date
2026-06-08
Publication Date
2026-07-17

AI Technical Summary

Technical Problem

Existing methods for producing liposome compositions are complex, require the use of toxic organic solvents, are difficult to scale up, and compromise the physical, chemical, and biological properties of the liposomes, leading to instability and low bioavailability of bioactive substances.

Method used

A liposome composition comprising powdered bioactive substances, phospholipids, and a protective agent, with a phospholipid coating thickness of 5-20% of the particle size and a relative humidity of 10% or less, prepared by spraying a phospholipid emulsion and a protective agent solution onto fluidized powder particles, followed by drying.

Benefits of technology

The method improves the stability and bioavailability of bioactive substances by ensuring uniform phospholipid and protective agent distribution, protecting the liposomes from environmental and mechanical damage, and allowing them to spontaneously form upon hydration, enhancing their commercial potential.

✦ Generated by Eureka AI based on patent content.
Patent Text Reader

Abstract

The invention belongs to the field of applied biotechnology, which is applied in the cosmetic, pharmaceutical and food industries, in particular for the production of professional, functional and nutritional foods. A liposome composition comprising a powdered bioactive substance, a phospholipid, a protective agent is described. Meanwhile, the covering thickness of the phospholipid on the particles of the powdery bioactive substance composition is 5-20% of the size of the particles of the powdery bioactive substance, and the relative humidity of the liposome composition does not exceed 10%.
Need to check novelty before this filing date? Find Prior Art